|
Recent Developments |
|
10-APR-14
Anuh Pharma has received approval from COFEPRIS (Health Authority of Mexico) GMP certificate for three of company's Erythromycin products.
06-AUG-10
Anuh Pharma, engaged in manufacturing and marketing of bulk drugs and chemicals today announced that it has approved issue of bonus shares in the ratio of 1:2, subject to permission of members.
23-JUN-10
Anuh Pharma engaged in the manufacture, marketing and export of bulk drugs and anti... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 30-Sep-2015(6) | 31-Mar-2015 (12) | 31-Mar-2014 (12) | | Net sales | 1782.85 | 2836.91 | 2663.98 | | Other Income | -5.60 | 22.65 | 5.61 | | Total Income | 1777.25 | 2859.56 | 2669.59 | | Cost of goods sold | 1534.15 | 2507.71 | 2396.32 | | OPBDIT | 243.10 | 351.85 | 273.27 | | PAT | 154.53 | 219.91 | 175.90 | | Gross Block | - | - | - | | Equity capital | 125.28 | 41.76 | 41.76 | | EPS (Rs.) | - | 26.33 | 21.06 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | 5.18 - 20.74 | 4.99 - 8.02 | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 13.7 | 12.3 | 10.2 | | Net margin (% of OI) | 8.7 | 7.7 | 6.6 |
|
|
Detailed Financials
|
|
|
|
|
